Cancer cells undergo extensive metabolic reprogramming to sustain their uncontrolled proliferation. This includes increased uptake of glucose and glutamine, alterations in lipid metabolism, and a shift towards anabolic pathways to support cell growth and division. The upregulation of enzymes like Hexokinase 2 and Lactate Dehydrogenase A is commonly observed, facilitating the enhanced glycolytic activity.
